Redirecting to deep profile of Sreenu Guntha at Aap Pharma Technologies, India Pvt Ltd...
Click here to continueBelow are the verified contact details to help you connect directly:
Email: sre*****@aap******.com
Mobile: 92081*****
Estimated Net Worth: ₹0 – ₹500+ Cr (approx. $0 – $60M)
- Sreenu Guntha founded AAP Pharma Technologies, India Pvt Ltd in January 2009, establishing a company focused on providing innovative pharmaceutical solutions.
- Under Sreenu Guntha's leadership, AAP Pharma Technologies has expanded its services and product offerings, contributing to advancements in pharmaceutical technology in India.
- Prior to founding AAP Pharma, Sreenu Guntha served as Senior Director at Sai Advantium Pharma Ltd from July 2007 until December 2008, driving key projects and initiatives within the organization.
- From February 2001 to July 2007, Sreenu Guntha held various roles at Albany Molecular Research Inc, starting as Senior Research Scientist II and advancing to Group Leader, indicating a strong background in research and development in the pharmaceutical sector.
- During the tenure at Albany Molecular Research Inc, Sreenu Guntha contributed to the development of significant pharmaceutical products, showcasing expertise in drug formulation and testing.
- Sreenu Guntha’s experience spans over two decades in the pharmaceutical industry, highlighting a robust understanding of the complexities and challenges faced in drug development and manufacturing.
- As a founder, Sreenu Guntha has faced challenges common in establishing new enterprises, including resource allocation, market competition, and regulatory compliance, which have been navigated successfully.
- AAP Pharma Technologies has become recognized in the industry for its commitment to quality and innovation, significantly impacting the competitive landscape of the Indian pharmaceutical market.